Wells Fargo’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $65.3K | Sell |
38,639
-79,336
| -67% | -$141K | ﹤0.01% | 5334 |
|
|
2025
Q4 | $168K | Buy |
117,975
+41,902
| +55% | +$61.1K | ﹤0.01% | 5164 |
|
|
2025
Q3 | $125K | Buy |
76,073
+12,234
| +19% | +$13.6K | ﹤0.01% | 5203 |
|
|
2025
Q2 | $46.7K | Sell |
63,839
-2,047
| -3% | -$1.77K | ﹤0.01% | 5528 |
|
|
2025
Q1 | $53.2K | Buy |
65,886
+4,056
| +7% | +$4.67K | ﹤0.01% | 5373 |
|
|
2024
Q4 | $85.3K | Buy |
61,830
+15,137
| +32% | +$17K | ﹤0.01% | 5286 |
|
|
2024
Q3 | $48.6K | Buy |
46,693
+1,754
| +4% | +$2.4K | ﹤0.01% | 5351 |
|
|
2024
Q2 | $77.7K | Buy |
44,939
+9,689
| +27% | +$19.5K | ﹤0.01% | 5091 |
|
|
2024
Q1 | $84.2K | Buy |
35,250
+6,144
| +21% | +$15.1K | ﹤0.01% | 4983 |
|
|
2023
Q4 | $96.9K | Sell |
29,106
-153,359
| -84% | -$411K | ﹤0.01% | 4922 |
|
|
2023
Q3 | $682K | Buy |
182,465
+146,300
| +405% | +$676K | ﹤0.01% | 3573 |
|
|
2023
Q2 | $154K | Sell |
36,165
-49,311
| -58% | -$291K | ﹤0.01% | 4746 |
|
|
2023
Q1 | $585K | Buy |
85,476
+79,889
| +1,430% | +$620K | ﹤0.01% | 3732 |
|
|
2022
Q4 | $44.2K | Sell |
5,587
-3,973
| -42% | -$30.6K | ﹤0.01% | 4917 |
|
|
2022
Q3 | $92K | Sell |
9,560
-1,150
| -11% | -$11.6K | ﹤0.01% | 4657 |
|
|
2022
Q2 | $78K | Sell |
10,710
-28,839
| -73% | -$251K | ﹤0.01% | 4787 |
|
|
2022
Q1 | $512K | Sell |
39,549
-21,163
| -35% | -$269K | ﹤0.01% | 4387 |
|
|
2021
Q4 | $969K | Sell |
60,712
-80,117
| -57% | -$1.4M | ﹤0.01% | 4135 |
|
|
2021
Q3 | $2.26M | Sell |
140,829
-107,706
| -43% | -$1.58M | ﹤0.01% | 3556 |
|
|
2021
Q2 | $3.44M | Sell |
248,535
-1,405
| -0.6% | -$19.9K | ﹤0.01% | 3213 |
|
|
2021
Q1 | $3.65M | Sell |
249,940
-71,825
| -22% | -$1.22M | ﹤0.01% | 3152 |
|
|
2020
Q4 | $5.59M | Sell |
321,765
-81,028
| -20% | -$1.44M | ﹤0.01% | 2643 |
|
|
2020
Q3 | $7.39M | Buy |
402,793
+10,250
| +3% | +$191K | ﹤0.01% | 2134 |
|
|
2020
Q2 | $7.01M | Buy |
392,543
+11,254
| +3% | +$190K | ﹤0.01% | 2148 |
|
|
2020
Q1 | $6.18M | Sell |
381,289
-115,670
| -23% | -$2.14M | ﹤0.01% | 2071 |
|
|
2019
Q4 | $8.95M | Buy |
496,959
+103,658
| +26% | +$1.91M | ﹤0.01% | 2047 |
|
|
2019
Q3 | $7.97M | Buy |
393,301
+128,278
| +48% | +$2.56M | ﹤0.01% | 2134 |
|
|
2019
Q2 | $5.86M | Sell |
265,023
-2,816
| -1% | -$48.9K | ﹤0.01% | 2430 |
|
|
2019
Q1 | $3.65M | Sell |
267,839
-577
| -0.2% | -$7.7K | ﹤0.01% | 2841 |
|
|
2018
Q4 | $2.43M | Buy |
268,416
+4,348
| +2% | +$50.3K | ﹤0.01% | 3103 |
|
|
2018
Q3 | $4.36M | Buy |
264,068
+18,313
| +7% | +$325K | ﹤0.01% | 2752 |
|
|
2018
Q2 | $3.44M | Buy |
245,755
+27,307
| +13% | +$391K | ﹤0.01% | 3012 |
|
|
2018
Q1 | $2.41M | Buy |
218,448
+5,658
| +3% | +$61.9K | ﹤0.01% | 3228 |
|
|
2017
Q4 | $1.87M | Buy |
212,790
+58,764
| +38% | +$629K | ﹤0.01% | 3410 |
|
|
2017
Q3 | $2.06M | Buy |
154,026
+124,910
| +429% | +$1.65M | ﹤0.01% | 3292 |
|
|
2017
Q2 | $418K | Buy |
29,116
+253
| +0.9% | +$4.87K | ﹤0.01% | 4336 |
|
|
2017
Q1 | $611K | Buy |
28,863
+6,245
| +28% | +$154K | ﹤0.01% | 4108 |
|
|
2016
Q4 | $637K | Buy |
22,618
+9,258
| +69% | +$259K | ﹤0.01% | 4032 |
|
|
2016
Q3 | $358K | Buy |
13,360
+1,354
| +11% | +$36.9K | ﹤0.01% | 4139 |
|
|
2016
Q2 | $203K | Sell |
12,006
-1,311
| -10% | -$24.6K | ﹤0.01% | 4402 |
|
|
2016
Q1 | $283K | Buy |
13,317
+4,388
| +49% | +$71.9K | ﹤0.01% | 4202 |
|
|
2015
Q4 | $205K | Buy |
8,929
+4,195
| +89% | +$108K | ﹤0.01% | 4443 |
|
|
2015
Q3 | $95K | Sell |
4,734
-730
| -13% | -$22.2K | ﹤0.01% | 4920 |
|
|
2015
Q2 | $158K | Buy |
5,464
+5,125
| +1,512% | +$130K | ﹤0.01% | 4742 |
|
|
2015
Q1 | $10K | Buy |
+339
| New | +$8.76K | ﹤0.01% | 5623 |
|
Other funds holding CHRS
VCM
SB
KKRC
CM
CWG